The Pan African Medical Journal (Apr 2016)

Prevalence of HBsAg, knowledge, and vaccination practice against viral hepatitis B infection among doctors and nurses in a secondary health care facility in Lagos state, South-western Nigeria

  • Abdul-Hakeem Olatunji Abiola,
  • Adebukola Bola Agunbiade,
  • Kabir Bolarinwa Badmos,
  • Adenike Olufunmilayo Lesi,
  • Abdulrazzaq Oluwagbemiga Lawal,
  • Quadri Olatunji Alli

DOI
https://doi.org/10.11604/pamj.2016.23.160.8710
Journal volume & issue
Vol. 23, no. 160

Abstract

Read online

INTRODUCTION: hepatitis B Virus, a highly infectious blood-borne virus poses a major threat to public health globally due to its high prevalence rate and grave consequence in causing liver cirrhosis and hepatocelullar carcinoma, the third cause of cancer death worldwide. The aim is determine the prevalence of HBsAg, knowledge, and vaccination practices against viral hepatitis B infection among doctors and nurses in a health care facility. METHODS: study design was a descriptive cross-sectional study among all the doctors and nurses in the health care facility. Data was collected using pre-tested, structured, self-administered questionnaire and blood samples were taken from respondents and tested using commercial enzyme-linked immunosorbent assay (ELIZA) test kit to determine prevalence of hepatitis B surface antigen after informed consent. Ethical approval was obtained from Health Research and Ethics Committee of the Lagos University Teaching Hospital. Responses of the respondents to the knowledge and vaccination practices against viral hepatitis B infection were scored and graded as poor (50%), fair (50-74%) and good (e"75%). The study was carried out in January, 2014. RESULTS: a total of 134 out of the 143 recruited respondents participated in the study. Prevalence of HBsAg was 1.5%. Among the respondents, 56.7% had good knowledge and 94.8% reported poor practice of vaccination against viral hepatitis B infection. Mean knowledge and vaccination practices scores (%) were 72.54+7.60 and 29.44+14.37 respectively. Only 29% of the respondents did post vaccination testing for anti HBsAg.

Keywords